4//SEC Filing
Eaton Bruce 4
Accession 0001415889-22-006162
CIK 0001650664other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:46 PM ET
Size
4.9 KB
Accession
0001415889-22-006162
Insider Transaction Report
Form 4
Eaton Bruce
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2022-06-03$11.54/sh−1,123$12,956→ 65,421 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units and in performance stock units on June 2, 2022. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001874831
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:46 PM ET
- Size
- 4.9 KB